Medication info
Amiforjjeong 5/80 mg

Amiforjjeong 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
IQURE Co., Ltd.
Appearance
Dark yellow round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201602314 · Approved 2016.04.25 · Insurance code 674400870

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
IQURE Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with either amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so you must stop taking it immediately if pregnancy is confirmed. Patients with hypersensitivity to this medication, pregnant or nursing women, patients with severe kidney or liver impairment, and those with a history of certain heart conditions or angioedema should not take this medication. Low blood pressure may occur if there is a deficiency of sodium or fluid in the body, so you should check your condition carefully before taking it, and appropriate treatment is required if symptoms of low blood pressure appear during treatment. Patients with high potassium levels or taking medications that can increase potassium levels should have their potassium levels checked regularly. Patients with poor kidney function, those who have received a kidney transplant, and patients with a history of angioedema should use this medication cautiously and should stop taking it immediately if symptoms occur. Patients with heart failure or post-myocardial infarction should carefully monitor their kidney function and blood pressure while taking this medication, and some heart disease patients may require special attention. This medication may interact with other antihypertensive medications or certain drugs, so you should consult with your doctor or pharmacist if you are taking other medications. Caution should be taken as dizziness or fatigue may occur when driving or operating machinery. In case of overdose, blood pressure may drop excessively, so maintain the exact dosage and contact a healthcare provider immediately if any unusual symptoms arise. This medication is not recommended for children under 18 years old, and elderly patients can take the same dose as adults. It is important to regularly check blood pressure, kidney function, and electrolyte levels during treatment to ensure there are no abnormalities.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, frequent urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbances, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, hives, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurosensitivity, sensory impairment, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. The recommended storage temperature is between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Dark yellow round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.